A detailed history of Ra Capital Management, L.P. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 10,416,609 shares of TYRA stock, worth $165 Million. This represents 3.41% of its overall portfolio holdings.

Number of Shares
10,416,609
Previous 10,416,609 -0.0%
Holding current value
$165 Million
Previous $167 Million 47.03%
% of portfolio
3.41%
Previous 2.51%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.45 - $20.22 $151 Million - $211 Million
10,416,609 New
10,416,609 $167 Million
Q1 2024

May 15, 2024

BUY
$11.61 - $20.0 $36.9 Million - $63.6 Million
3,180,155 Added 43.95%
10,416,609 $171 Million
Q4 2023

Feb 14, 2024

BUY
$11.01 - $14.95 $79.7 Million - $108 Million
7,236,454 New
7,236,454 $100 Million
Q3 2021

Nov 15, 2021

BUY
$16.91 - $26.0 $122 Million - $188 Million
7,236,454 New
7,236,454 $127 Million

Others Institutions Holding TYRA

About Tyra Biosciences, Inc.


  • Ticker TYRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,973,600
  • Market Cap $664M
  • Description
  • Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...
More about TYRA
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.